High education may offer protection against tauopathy in patients with mild cognitive impairment

Journal of Alzheimer's Disease

Volumn 21, Issue 1, 2010, Pages 221-228

  Rolstad, Sindre ^a   Nordlund, Arto ^a   Eckerström, Carl ^a   Gustavsson, Marie H ^a   Blennow, Kaj ^a   Olesen, Pernille J ^a   Zetterberg, Henrik ^a   Wallin, Anders ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Brain reserve; cognitive reserve; education; mild cognitive impairment; neurochemical biomarkers

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; COGNITION; CONTROLLED STUDY; EDUCATIONAL STATUS; ELECTRIC POTENTIAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROPHYLAXIS; TAUOPATHY; COGNITIVE DEFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; LONGITUDINAL STUDY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

AGED; AMYLOID BETA-PEPTIDES; COGNITION DISORDERS; EDUCATIONAL STATUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PSYCHIATRIC STATUS RATING SCALES; STATISTICS, NONPARAMETRIC; TAU PROTEINS;

EID: 77954980202     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-091012     Document Type: Article

References (53)

1. Satz P (1993) Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology 7, 273-295.
2. Stern Y (2002) What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8, 448-460.
3. Diamond M (1988) Enriching heredity: the impact of the environment on the anatomy of the brain, Free Press, New York, NY.
4. Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS (2005) Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120, 701-713.
5. van Praag H, Shubert T, Zhao C, Gage FH (2005) Exercise enhances learning and hippocampal neurogenesis in aged mice. JNeurosci 25, 8680-8685.
6. Stern Y (2009) Cognitive reserve. Neuropsychologia 47, 20152028.
7. Valenzuela MJ, Sachdev P (2006) Brain reserve and dementia: a systematic review. Psychol Med 36, 441-454.
8. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R (1994) Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271, 1004-1010.
9. Verghese J, Lipton RB, Katz MJ, Hall CB, Derby CA, Kuslan-sky G, Ambrose AF, Sliwinski M, Buschke H (2003) Leisure activities and the risk of dementia in the elderly. N Engl J Med 348, 2508-2516. (Pubitemid 36706538)
10. Fritsch T, Smyth KA, McClendon MJ, Ogrocki PK, Santillan C, Larsen JD, Strauss ME (2005) Associations between dementia/mild cognitive impairment and cognitive performance and activity levels in youth. J Am Geriatr Soc 53, 1191-1196.
11. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erk-injuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246.
12. Schofield PW, Mosesson RE, Stern Y, Mayeux R (1995) The age at onset of Alzheimer's disease and an intracranial area measurement. A relationship. Arch Neurol 52, 95-98.
13. Mori E, Hirono N, Yamashita H, Imamura T, Ikej iri Y, Ikeda M, Kitagaki H, Shimomura T, Yoneda Y (1997) Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease. Am J Psychiatry 154, 18-24.
14. Edland SD, Xu Y, Plevak M, O'Brien P, Tangalos EG, Petersen RC, Jack CR, Jr. (2002) Total intracranial volume: normative values and lack of association with Alzheimer's disease. Neurology 59, 272-274.
15. MacLullich AM, Ferguson KJ, Deary IJ, Seckl JR, Starr JM, Wardlaw JM (2002) Intracranial capacity and brain volumes are associated with cognition in healthy elderly men. Neurology 59, 169-174.
16. Wolf H, Kruggel F, Hensel A, Wahlund LO, Arendt T, Gertz HJ (2003) The relationship between head size and intracranial volume in elderly subjects. Brain Res 973, 74-80.
17. Gale CR, Walton S, Martyn CN (2003) Foetal and postnatal head growth and risk of cognitive decline in old age. Brain 126, 2273-2278.
18. Borenstein Graves A, Mortimer JA, Bowen JD, McCormick WC, McCurry SM, Schellenberg GD, Larson EB (2001) Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology 57, 1453-1460.
19. Graves AB, Mortimer JA, Larson EB, Wenzlow A, Bowen JD, McCormick WC (1996) Head circumference as a measure of cognitive reserve. Association with severity of impairment in Alzheimer's disease. Br J Psychiatry 169, 86-92.
20. Kemppainen NM, Aalto S, Karrasch M, Nagren K, Savisto N, Oikonen V, Viitanen M, Parkkola R, Rinne JO (2008) Cog nitive reserve hypothesis: Pittsburgh Compound B and fluo-rodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol 63, 112118.
21. Alexander GE, Furey ML, Grady CL, Pietrini P, Brady DR, Mentis MJ, Schapiro MB (1997) Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. Am J Psychiatry 154, 165-172.
22. Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, Marder KS, Bell KL, Sackeim HA, Van Heertum RL, Moeller JR, Stern Y (2003) Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 60, 359-365.
23. Blennow K (2004) CSF biomarkers for mild cognitive impairment. J Intern Med 256, 224-234.
24. Blennow K (2004) Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 1, 213-225.
25. Rolstad S, Nordlund A, Eckerstrom C, Gustavsson MH, Zetter-berg H, Wallin A (2009) Cognitive reserve in relation to Abe-ta42 in patients converting from MCI to dementia-A follow-up report. Dement Geriatr Cogn Disord 28, 110-115.
26. Rolstad S, Nordlund A, Eckerstrom C, Gustavsson MH, Zetter-berg H, Wallin A (2009) Biomarkers in relation to cognitive reserve in patients with mild cognitive impairment-proof of concept. Dement Geriatr Cogn Disord 27, 194-200.
27. Nordlund A, Rolstad S, Hellstrom P, Sjogren M, Hansen S, Wallin A (2005) The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition. J Neurol Neurosurg Psychiatry 76, 1485-1490.
28. Reisberg B, Ferris SH, de Leon MJ, Crook T (1988) Global Deterioration Scale (GDS). Psychopharmacol Bull 24, 661663.
29. Nordlund A, Rolstad S, Klang O, Lind K, Hansen S, Wallin A (2007) Cognitive profiles of mild cognitive impairment with and without vascular disease. Neuropsychology 21, 706-712.
30. (1996) Assessment: neuropsychological testing of adults. Considerations for neurologists. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 47, 592-599.
31. Zetterberg H, Pedersen M, Lind K, Svensson M, Rolstad S, Eckerstrom C, Syversen S, Mattsson UB, Ysander C, Mattsson N, Nordlund A, Vanderstichele H, Vanmechelen E, Jonsson M, Edman A, Blennow K, Wallin A (2007) Intra-individual stability of CSF biomarkers for Alzheimer's disease over two years. JAlzheimers Dis 12, 255-260. (Pubitemid 350179256)
32. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Van-mechelen E (1995) Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? Mol Chem Neuropathol 26, 231-245.
33. Andreasen N, Hesse C, Davidsson P, Minthon L, Wallin A, Winblad B, Vanderstichele H, Vanmechelen E, Blennow K (1999) Cerebrospinal fluid beta amyloid(1-42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol 56, 673-680.
34. Blennow K, Ricksten A, Prince JA, Brookes AJ, Emahazion T, Wasslavik C, Bogdanovic N, Andreasen N, Batsman S, Mar-cusson J, Nagga K, Wallin A, Regland B, Olofsson H, Hesse C, Davidsson P, Minthon L, Jansson A, Palmqvist L, Rymo L (2000) No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression. J Neural Transm 107, 1065-1079.
35. Strozyk D, Blennow K, White LR, Launer LJ (2003) CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology 60, 652-656.
36. Arnaiz E, Almkvist O, Ivnik RJ, Tangalos EG, Wahlund LO, Winblad B, Petersen RC (2004) Mild cognitive impairment: a cross-national comparison. J Neurol Neurosurg Psychiatry 75, 1275-1280.
37. Butler SM, Ashford JW, Snowdon DA (1996) Age, education, and changes in the Mini-Mental State Exam scores of older women: findings from the Nun Study. J Am Geriatr Soc 44, 675-681.
38. Rolstad S, Nordlund, A., Eckerstrom, C., Gustavsson, M, H., Zetterberg, H. and Wallin, A. (2009) Biomarkers in relation to cognitive reserve in patients with Mild Cognitive Impairment-proof of concept. Dement Geriatr Cogn Disord 27, 194-200.
39. Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256, 183-194.
40. Rentz DM, Huh TJ, Faust RR, Budson AE, Scinto LF, Sperling RA, Daffner KR (2004) Use of IQ-adjusted norms to predict progressive cognitive decline in highly intelligent older individuals. Neuropsychology 18, 38-49.
41. Rentz DM, Sardinha LM, Huh TJ, Searl MM, Daffner KR, Sperling RA (2006) IQ-based norms for highly intelligent adults. Clin Neuropsychol 20, 637-648.
42. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L (2006) Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5, 228-234.
43. Zetterberg H, Wahlund LO, Blennow K (2003) Cerebrospinal fluid markers for prediction of Alzheimer's disease. Neurosci Lett 352, 67-69.
44. Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW, Jr., Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ (2003) Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60, 1696-1702.
45. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosen E, Aarsland D, Visser PJ, Schroder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttila T, Wallin A, Jonhagen ME, Minthon L, Winblad B, Blennow K (2009) CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302, 385-393.
46. Nordlund A, Rolstad S, Klang O, Lind K, Pedersen M, Blennow K, Edman A, Hansen S, Wallin A (2008) Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI. JIntNeuropsy-chol Soc 14, 582-590.
47. Riley KP, Snowdon DA, Desrosiers MF, Markesbery WR (2005) Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiol Aging 26,341-347.
48. Snowdon DA, Greiner LH, Markesbery WR (2000) Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrov ascular disease. Findings from the Nun Study. Ann N YAcad Sci 903, 34-38.
49. Mortimer JA, Snowdon DA, Markesbery WR (2008) Small head circumference is associated with less education in persons at risk for Alzheimer disease in later life. Alzheimer Dis Assoc Disord 22, 249-254.
50. Willerman L, Schultz, R, Rutledge, JN, Bigler, E (1991) In vivo brain size and intelligence. Intelligence 15, 223-228.
51. Neisser U, Gwyneth, B, Bouchard, TJ, Thomas J Jr, Boykin, AW, Brody, N, Ceci, SJ, Halpern, DF, Loehlin, JC, Perloff, R, Sternberg, RJ, Urbina, S (1996) Intelligence: Knowns and unknowns. American Psychologist 51, 77-101.
52. Ashford JW, Soultanian NS, Zhang SX, Geddes JW (1998) Neuropil threads are collinear with MAP2 immunostaining in neuronal dendrites of Alzheimer brain. J Neuropathol Exp Neurol 57, 972-978.
53. Brown J, Cooper-Kuhn CM, Kempermann G, Van Praag H, Winkler J, Gage FH, Kuhn HG (2003) Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur J Neurosci 17, 2042-2046.